These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3022277)

  • 1. Chemical carcinogenesis: the liver as a model.
    Farber E; Sarma DS
    Pathol Immunopathol Res; 1986; 5(1):1-28. PubMed ID: 3022277
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell biology of hepatocarcinogenesis.
    Saeter G; Seglen PO
    Crit Rev Oncog; 1990; 1(4):437-66. PubMed ID: 1964598
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor promotion in the liver.
    Schulte-Hermann R
    Arch Toxicol; 1985 Aug; 57(3):147-58. PubMed ID: 3904674
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathobiology of chemical hepatocarcinogenesis: recent progress and perspectives. Part I. Cytomorphological changes and cell proliferation.
    Bannasch P
    J Gastroenterol Hepatol; 1990; 5(2):149-59. PubMed ID: 1966478
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro.
    Moore MA; Kitagawa T
    Int Rev Cytol; 1986; 101():125-73. PubMed ID: 3009348
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimal neoplasias in experimental liver carcinogenesis.
    Rabes HM
    Recent Results Cancer Res; 1988; 106():21-7. PubMed ID: 3285413
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dibutylnitrosamine and saccharin on glutamyl transpeptidase-positive foci and liver cancer.
    Pereira MA; Herren SL; Britt AL
    Environ Health Perspect; 1983 Apr; 50():169-76. PubMed ID: 6135608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular events during hepatocarcinogenesis in rats and the question of premalignancy.
    Sell S; Hunt JM; Knoll BJ; Dunsford HA
    Adv Cancer Res; 1987; 48():37-111. PubMed ID: 2441577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically motivated cancer risk models.
    Thorslund TW; Brown CC; Charnley G
    Risk Anal; 1987 Mar; 7(1):109-19. PubMed ID: 3615992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver tumour promotion by phenobarbital: comparison of rat and human studies.
    McLean AE; Driver HE; Sutherland IA
    Prog Clin Biol Res; 1992; 374():251-9. PubMed ID: 1320274
    [No Abstract]   [Full Text] [Related]  

  • 11. Aflatoxicosis in coho salmon.
    Halver JE; Ashley LM; Smith RR
    Natl Cancer Inst Monogr; 1969 Jul; 31():141-55. PubMed ID: 4318094
    [No Abstract]   [Full Text] [Related]  

  • 12. An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in rat liver.
    Gindi T; Ghazarian DM; Deitch D; Farber E
    Cancer Lett; 1994 Aug; 83(1-2):75-80. PubMed ID: 8062236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of hepatocarcinogenesis in rainbow trout with carbon tetrachloride.
    Kotsanis N; Metcalfe CD
    Bull Environ Contam Toxicol; 1991 Jun; 46(6):879-86. PubMed ID: 1863795
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of postnecrotic cirrhosis on aflatoxin carcinogenesis in rats.
    Sun SC; Wei RD; Schaeffer BT
    Lab Invest; 1971 May; 24(5):368-72. PubMed ID: 4326522
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic instability occurs sooner than expected: promotion, progression and clonality during hepatocarcinogenesis in the rat.
    Sudilovsky O; Hinrichsen LI; Hei TK; Whitacre CM; Wang JH; Kasturi S; Jiang SH; Cechner R; Miron S; Abdul-Karim F
    Basic Life Sci; 1991; 57():263-77. PubMed ID: 1667572
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of hyperplasia in liver carcinogenesis.
    Mirsalis JC; Steinmetz KL
    Prog Clin Biol Res; 1990; 331():149-61. PubMed ID: 2179957
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene.
    Altavilla G; Caputo A; Lanfredi M; Piola C; Barbanti-Brodano G; Corallini A
    Am J Pathol; 2000 Oct; 157(4):1081-9. PubMed ID: 11021811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive effect and promotor activity for hepatic carcinogenesis of thiobenzamide].
    Pasquinelli P; Bruschi F; Saviozzi M; Malvaldi G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):61-6. PubMed ID: 3884022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multistage hepatocarcinogenesis in the rat: insights into risk estimation.
    Dragan YP; Pitot HC
    Prog Clin Biol Res; 1992; 374():261-79. PubMed ID: 1620707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.